Stomach Cancer Trial, Recruiting NCT04949282 Sponsor: Sociedad Española de Medicina Nuclear e Imagen Molecular Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04949282
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with a somatostatin receptor-positive tumour (a specific type of tumour that shows up on certain scans) that has either spread to other parts of the body or cannot be surgically removed, and that has continued to grow or progress
  • People who are willing and able to give written agreement to take part before any information is collected

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mercedes Dr Mitjavila Casanovas, MD-PhD, Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM)

Phone: 911916000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sociedad Española de Medicina Nuclear e Imagen Molecular
Registry
ClinicalTrials.gov
Start date
10 May 2021
Est. completion
31 December 2034

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Progression Free Survival (PFS); Overall survival (OS); Overall response rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov